Literature DB >> 16122709

A pH-dependent increase in neuronal glutamate efflux in vitro: possible involvement of ASCT1.

Michael D Weiss1, Candace Rossignol, Colin Sumners, Kevin J Anderson.   

Abstract

Efflux of glutamate from intracellular pools during hypoxia-ischemia has been postulated to be mediated by amino acid transporters and can lead to excitotoxicity. In addition, a decrease in pH seen during global hypoxia-ischemia may influence which transporter is responsible for this glutamate efflux. For example, the neutral amino acid transporter ASCT1 is an effective transporter of glutamate at low pH. We have examined the effects of pH, pH and temperature, and hypoxia on glutamate efflux in a rat primary neuronal cell culture model. We observed a marked increase of glutamate efflux as pH was decreased from 7.4 to 5.5. This pH-dependent efflux is likely due to a transporter-mediated process because it was seen in the presence of tetrodotoxin and was blunted by decreasing the temperature to either 35 degrees C or 33 degrees C. In addition, no increase in LDH was seen at pH 5.5 suggesting that increased glutamate levels were not due to cellular death. No change in glutamate levels was seen when the oxygen tension of the medium was lowered from 150 mm Hg to either 30 or 15 mm Hg. Given that EAAT transporters are inhibited by low pH, other transporters, such as ASCT1, may be responsible for this pH-dependent efflux of glutamate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122709     DOI: 10.1016/j.brainres.2005.07.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  The detrimental role of glial acidification during ischemia.

Authors:  Steven A Sloan; Ben A Barres
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

Review 2.  The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia.

Authors:  Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

Review 3.  Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).

Authors:  Johanna Huttunen; Santosh Kumar Adla; Magdalena Markowicz-Piasecka; Kristiina M Huttunen
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.